• Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Menu
  • Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Facebook
THE EFFECT OF MATERNAL BODY MASS INDEX ON PREGNANCY OUTCOME IN CORRELATION WITH PLACENTAL PATHOLOGY
Home ‹ 2014 Abstracts ‹ THE EFFECT OF MATERNAL BODY MASS INDEX ON PREGNANCY OUTCOME IN CORRELATION WITH PLACENTAL PATHOLOGY

Michal Kovo 1, Elena Saruhanov 1,Letizia Schreiber 2,Noa Mevorach 1, Jacob Bar 1

Depts. of Obstetrics & Gynecology1 and Pathology2, the E. Wolfson Medical Center, Holon, and Sackler Faculty of Medicine, Tel Aviv University, Israel

 

Objectives: To investigate the effect of maternal obesity on pregnancy outcome and placental histopathology.

Study design: Pregnancy outcome and placental histology from complicated term pregnancy, between 2007- 2012, were reviewed.  Women were divided according to their pre-pregnancy body mass index (BMI) (kg/m2); normal weight (18-24.9), overweight (25-29.9) and obese (≥30). Results were compared between the groups. In addition, pregnancy outcome and placental histology were compared between obese and control group with uncomplicated pregnancies, matched on 1:2 basis by mode of delivery. Placental lesions were classified as lesions of maternal or fetal vascular supply, and maternal (MIR) and fetal (FIR) inflammatory responses.

Results:  Of the 1,047 women analyzed, 615 were with normal weight (BMI 21.75±1.8), 211 with overweight (BMI 27±1.3) and 221 obese (BMI 35.2±4.3). Overweight and obesity were associated with higher rate of diabetes and hypertensive disorders (p=0.001 for all), higher rate of birth-weight >90th(p<0.001), and higher rate of CS, p<0.001. Placental weight was higher in obese than in overweight or normal weight women, p<0.001. No difference was observed in the rate of placental lesions related to maternal or fetal vascular supply, MIR or FIR between the three sub-groups.  However, higher rate of maternal placental vascular lesions, 46.8% vs. 28.2%, p=0.012, were observed in uncomplicated obese patients (n=62) as compared with healthy normal-weight (n=124) uncomplicated controls.

Conclusion: Pregnancy outcome is worse without different placental component in obese vs. normal weight women, with complicated pregnancies. However, in uncomplicated pregnancies, more maternal placental vascular supply lesions exist in obese vs. normal-weight women.

Table: Placental pathology of healthy obese and non-obese patients with uncomplicated pregnancies

 

p-value Controls

n=124

Obese

n=62

0.316 476.5±104.7 494.2±127.4 Placental weight (gr)
0.857 6.7±1.1 6.8±1.2 Fetal-placental ratio
 
0.012 35 (28.2%) 29 (46.8%) Composite maternal vascular supply lesions (%)
0.615 1 (0.8%) 1 (1.61%) Placental hemorrhage (%)
0.073 1 (0.8%) 3 (4.9%) Vascular lesions related to maternal under perfusion (%)
0.060 35 (28.2%) 26 (41.9%) Villous changes related to maternal under perfusion (%)
0.224 14 (11.3%) 11 (17.7%) Composite fetal vascular supply lesions (%)
0.468 7 (5.6%) 2 (3.2%) Vascular lesions consistent with FTOD (%)
0.199 12 (9.7%) 10 (16.1%) Villous lesions consistent with FTOD (%)
1 24 (19.3%) 12 (19.3%) MIR
0.357 8 (6.4%) 2 (3.2%) FIR

 

Continuous variables are presented as mean ± SD and categorical variables as n (%).  FTOD – fetal thrombo-occlusive disease, FIR- fetal inflammatory response, MIR- maternal inflammatory response

« Previous
Next »
Powered by Netmii and Art + Web
All rights reserved to ISPR -Israel Society for Placental Research
Scroll to top